Cite

HARVARD Citation

    Howard, D. et al. (2016). Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial. Trials. 17 (1), pp. 1-11. [Online]. 
  
Back to record